Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID), 55888 [2018-24462]

Download as PDF 55888 Federal Register / Vol. 83, No. 217 / Thursday, November 8, 2018 / Notices a draft NORA Agenda entitled National Occupational Research Agenda for Immune, Infectious and Dermal Disease Prevention (IID) for public comment. To view the notice and related materials, visit https://www.regulations.gov and enter CDC–2018–0103 in the search field and click ‘‘Search.’’ Table of Contents • • • • • Dates Addresses For Further Information Contact Supplementary Information Background Electronic or written comments must be received by January 7, 2019. ADDRESSES: You may submit comments, identified by CDC–2018–0103 and docket number NIOSH–322, by any of the following methods: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. • Mail: National Institute for Occupational Safety and Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C–34, Cincinnati, Ohio 45226–1998. Instructions: All submissions received in response to this notice must include the agency name and docket number [CDC–2018–0103; NIOSH–322]. All relevant comments received will be posted without change to https:// www.regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to https://www.regulations.gov. All information received in response to this notice will also be available for public examination and copying at the NIOSH Docket Office, 1150 Tusculum Avenue, Room 155, Cincinnati, OH 45226–1998. FOR FURTHER INFORMATION CONTACT: Emily Novicki (NORACoordinator@ cdc.gov), National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Mailstop E–20, 1600 Clifton Road NE, Atlanta, GA 30329, phone (404) 498– 2581 (not a toll free number). SUPPLEMENTARY INFORMATION: The National Occupational Research Agenda (NORA) is a partnership program created to stimulate innovative research and improved workplace practices. The national agenda is developed and implemented through the NORA sector and cross-sector councils. Each council develops and maintains an agenda for its sector or cross-sector. Background: The National Occupational Research Agenda for Immune, Infectious and Dermal Disease Prevention (IID) is intended to identify the research, information, and actions most urgently needed to prevent daltland on DSKBBV9HB2PROD with NOTICES DATES: VerDate Sep<11>2014 16:51 Nov 07, 2018 Jkt 247001 occupational disease. The document provides a vehicle for stakeholders to describe the most relevant issues, gaps, and safety and health needs for the sector. Each NORA research agenda is meant to guide or promote high priority research efforts on a national level, conducted by various entities, including: Government, higher education, and the private sector. This is the first IID Agenda, developed for the third decade of NORA (2016–2026). The agenda was developed considering information about injuries, the state of the science, and the probability that new information and approaches will make a difference. As the steward of the NORA process, NIOSH invites comments on the draft National Occupational Research Agenda for Immune, Infectious and Dermal Disease Prevention (IID). Comments expressing support or with specific recommendations to improve the Agenda are requested. A copy of the draft Agenda is available at https:// www.regulations.gov (see Docket Number CDC–2018–0103). Frank J. Hearl, Chief of Staff, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2018–24443 Filed 11–7–18; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID). This meeting is open to the public, limited only by the space available; the meeting room will accommodate up to 100 people. The public is also welcome to listen to the meeting by telephone, limited only by the number of ports available (50); the toll-free dial-in number is 1–877–951–7311, with a pass code of 4123441. DATES: The meeting will be held on December 5, 2018, 8:30 a.m. to 5 p.m., EST, and December 6, 2018, 8:30 a.m. to 12 p.m., EST. SUMMARY: PO 00000 Frm 00038 Fmt 4703 Sfmt 9990 CDC, Global Communications Center, 1600 Clifton Road NE, Building 19, Auditorium B3, Atlanta, Georgia 30329–4027; also 1– 877–951–7311, with a pass code of 4123441. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Sarah Wiley, MPH, Designated Federal Officer, CDC, 1600 Clifton Road NE, Mailstop H24–12, Atlanta, Georgia 30329–4027, Telephone (404) 639–4840; sed5@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The BSC, OID, provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the OID, CDC; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: Strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers. Matters to be Considered: The agenda will include updates from the infectious disease national centers and the Center for Global Health along with focused discussions on recent outbreaks and affected populations. Reports back from two workgroups will also be given: (1) The Board’s Food Safety Modernization Act Surveillance Working Group and (2) the Vector-borne Diseases Workgroup of the BSC, OID, and the Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2018–24462 Filed 11–7–18; 8:45 am] BILLING CODE 4163–19–P E:\FR\FM\08NON1.SGM 08NON1

Agencies

[Federal Register Volume 83, Number 217 (Thursday, November 8, 2018)]
[Notices]
[Page 55888]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24462]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Office of Infectious Diseases 
(BSC, OID)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
Office of Infectious Diseases (BSC, OID). This meeting is open to the 
public, limited only by the space available; the meeting room will 
accommodate up to 100 people. The public is also welcome to listen to 
the meeting by telephone, limited only by the number of ports available 
(50); the toll-free dial-in number is 1-877-951-7311, with a pass code 
of 4123441.

DATES: The meeting will be held on December 5, 2018, 8:30 a.m. to 5 
p.m., EST, and December 6, 2018, 8:30 a.m. to 12 p.m., EST.

ADDRESSES: CDC, Global Communications Center, 1600 Clifton Road NE, 
Building 19, Auditorium B3, Atlanta, Georgia 30329-4027; also 1-877-
951-7311, with a pass code of 4123441.

FOR FURTHER INFORMATION CONTACT: Sarah Wiley, MPH, Designated Federal 
Officer, CDC, 1600 Clifton Road NE, Mailstop H24-12, Atlanta, Georgia 
30329-4027, Telephone (404) 639-4840; [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The BSC, OID, provides advice and guidance to the 
Secretary, Department of Health and Human Services; the Director, CDC; 
the OID, CDC; and the Directors of the National Center for Immunization 
and Respiratory Diseases, the National Center for Emerging and Zoonotic 
Infectious Diseases, and the National Center for HIV/AIDS, Viral 
Hepatitis, STD, and TB Prevention, CDC, in the following areas: 
Strategies, goals, and priorities for programs; research within the 
national centers; and overall strategic direction and focus of OID and 
the national centers.
    Matters to be Considered: The agenda will include updates from the 
infectious disease national centers and the Center for Global Health 
along with focused discussions on recent outbreaks and affected 
populations. Reports back from two workgroups will also be given: (1) 
The Board's Food Safety Modernization Act Surveillance Working Group 
and (2) the Vector-borne Diseases Workgroup of the BSC, OID, and the 
Board of Scientific Counselors, National Center for Environmental 
Health/Agency for Toxic Substances and Disease Registry. Agenda items 
are subject to change as priorities dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-24462 Filed 11-7-18; 8:45 am]
 BILLING CODE 4163-19-P